Description
DAPAFLO 10MG is a medication containing Dapagliflozin 10 mg, an active pharmaceutical ingredient classified as a Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor. This cutting-edge drug works by preventing the kidneys from reabsorbing glucose back into the bloodstream, leading to its excretion in the urine. Beyond its primary role in blood sugar control, Dapagliflozin also promotes the removal of sodium and water from the body, offering significant benefits for cardiovascular and renal health.
DAPAFLO 10MG is widely prescribed for the management of Type 2 Diabetes Mellitus, where it helps lower blood glucose levels. Crucially, its indications extend to Heart Failure (with reduced, mildly reduced, or preserved ejection fraction), reducing the risk of cardiovascular death and hospitalizations, and for patients with Chronic Kidney Disease (CKD), slowing disease progression and reducing associated risks. As a prescription-only medication, it is taken once daily. Patients should be aware of potential side effects such as genitourinary infections and the rare but serious risk of diabetic ketoacidosis.
